Fig. 1From: CT-based radiomics signature of visceral adipose tissue and bowel lesions for identifying patients with Crohn’s disease resistant to infliximabThe study flow chart (upper) and the radiomics analysis workflow (lower) (VAT model, radiomics model based on features extracted from visceral adipose tissue; bowel model, radiomics model based on features extracted from the inflamed bowel; VAT-bowel model, a combination of the VAT model and bowel model)Back to article page